Table 1.
Role of Autophagy in Various Liver Diseases and the Agents Targeting Autophagy.
Liver disease | Hepatic autophagy level | Role of autophagy | Autophagy modulation | Agents used to target autophagy |
---|---|---|---|---|
Fatty liver disease | Decreased | Lipid degradation, insulin signaling | Autophagy inducers | TORIN-1, Rapamycin |
Alcoholic liver disease | Decreased | Degradation of protein aggregates and damaged organelles | Autophagy inducers | TORIN-1, Rapamycin |
Hepatocellular carcinoma | Decreased | Anti-tumor effect in normal cells; Autophagy is used by cancer cells for survival against apoptosis by traditional chemotherapeutic drugs |
Autophagy inducers | Rapamycin, Everolimus, Bortezomib, Sorafenib, NPC-16, |
Autophagy inhibitors | 3MA, Chloroquine, SiRNA, MicroRNAs | |||
HBV Infection | Increased | Autophagy subverted by virus | Autophagy suppressor | 3MA |
Autophagy inducer | Rapamycin | |||
HCV infection | Increased | Autophagy subverted by virus | Autophagy suppressor | 3MA, Chloroquine |
Autophagy inducer | Rapamycin | |||
A1-AT deficiency | – | Autophagy clears the AT protein aggregation | mTOR independent increase in autophagy | Carbamazepine |